Publisher Correction: Detection of PD-L1 in the urine of patients with urothelial carcinoma of the bladder

被引：0
|
作者：
Georgi Tosev
Wasilijiang Wahafu
Philipp Reimold
Ivan Damgov
Constantin Schwab
Cem Aksoy
Adam Kaczorowski
Albrecht Stenzinger
Joanne Nyarangi‑Dix
Markus Hohenfellner
Stefan Duensing
机构：
[1] University Hospital Heidelberg,Department of Urology
[2] Chinese Academy of Medical Sciences and Peking Union Medical College,Department of Urology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital
[3] University of Heidelberg,Division of Pediatric Nephrology, Center for Pediatric and Adolescent Medicine
[4] University of Heidelberg,Institute of Medical Biometry and Informatics
[5] Heidelberg University Hospital,Department of General Pathology, Institute of Pathology
[6] University Hospital Heidelberg,Molecular Urooncology
来源：
Scientific Reports | / 11卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Detection of PD-L1 in the urine of patients with urothelial carcinoma of the bladder (vol 9, 14244, 2021)
    Tosev, Georgi
    Wahafu, Wasilijiang
    Reimold, Philipp
    Damgov, Ivan
    Schwab, Constantin
    Aksoy, Cem
    Kaczorowski, Adam
    Stenzinger, Albrecht
    Nyarangi-Dix, Joanne
    Hohenfellner, Markus
    Duensing, Stefan
    [J]. SCIENTIFIC REPORTS, 2021, 11 (01)
  • [2] PD-L1 Protein Expression and PD-L1 Gene Amplification in Urothelial Carcinoma of the Urinary Bladder
    Zuo, Chunlai
    Kallakury, Bhaskar V. S.
    Firestone, Bryan
    Voronel, Olga
    Sheehan, Christine E.
    Nazeer, Tipu
    Ross, Jeffrey S.
    [J]. MODERN PATHOLOGY, 2016, 29 : 272A - 272A
  • [3] PD-L1 Protein Expression and PD-L1 Gene Amplification in Urothelial Carcinoma of the Urinary Bladder
    Zuo, Chunlai
    Kallakury, Bhaskar V. S.
    Firestone, Bryan
    Voronel, Olga
    Sheehan, Christine E.
    Nazeer, Tipu
    Ross, Jeffrey S.
    [J]. LABORATORY INVESTIGATION, 2016, 96 : 272A - 272A
  • [4] PD-L1 blockade for urothelial carcinoma
    Kang, Josephine
    Galluzzi, Lorenzo
    [J]. ONCOIMMUNOLOGY, 2017, 6 (07):
  • [5] Correction to: PD-L1 expression in bladder primary in situ urothelial carcinoma: evaluation in BCG-unresponsive patients and BCG responders
    Francesco Pierconti
    Maria Rosaria Raspollini
    Maurizio Martini
    Luigi Maria Larocca
    Pier Francesco Bassi
    Riccardo Bientinesi
    Gianna Baroni
    Andrea Minervini
    Guido Petracco
    Giacomo Maria Pini
    Carlo Patriarca
    [J]. Virchows Archiv, 2020, 477 : 327 - 327
  • [6] PD-L1 Antibody Comparison in Urothelial Carcinoma
    Rijnders, Maud
    van der Veldt, Astrid A. M.
    Zuiverloon, Tahlita C. M.
    Grunberg, Katrien
    Thunnissen, Erik
    de Wit, Ronald
    van Leenders, Geert J. L. H.
    [J]. EUROPEAN UROLOGY, 2019, 75 (03) : 538 - 540
  • [7] Evaluation of PD-L1 expression on circulating tumor cells (CTCs) in patients with advanced urothelial carcinoma of the bladder
    Bergmann, Sonja
    Coym, Anja
    von Amsberg, Gunhild
    Janning, Melanie
    Soave, Armin
    Rink, Michael
    Pantel, Klaus
    Riethdorf, Sabine
    [J]. CANCER RESEARCH, 2019, 79 (13)
  • [8] PD-L1 Immunohistochemistry Assay Concordance in Urothelial Carcinoma of the Bladder and Hypopharyngeal Squamous Cell Carcinoma
    Hodgson, Anjelica
    Slodkowska, Elzbieta
    Jungbluth, Achim
    Liu, Stanley K.
    Vesprini, Danny
    Enepekides, Danny
    Higgins, Kevin
    Katabi, Nora
    Xu, Bin
    Downes, Michelle R.
    [J]. AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2018, 42 (08) : 1059 - 1066
  • [9] Soluble PD-L1 in Serum and Urine in Urinary Bladder Cancer Patients
    Vikerfors, Anders
    Davidsson, Sabina
    Frey, Janusz
    Jerlstrom, Tomas
    Carlsson, Jessica
    [J]. CANCERS, 2021, 13 (22)
  • [10] The evolving role of PD-L1 testing in patients with metastatic urothelial carcinoma
    Powles, Thomas
    Walker, Jill
    Williams, J. Andrew
    Bellmunt, Joaquim
    [J]. CANCER TREATMENT REVIEWS, 2020, 82
12345